← Company intelligence

Robot maker · registered

Mendaera

Corporate marketmedicalCurated record

Focalist handheld robotic system pairs real-time ultrasound imaging with touchscreen targeting and AI-driven robotic needle positioning; continuous depth tracking and automatic needle repositioning delivers precise ultrasound-guided placement for biopsies, vascular access, and pain management; integrates Butterfly Network ultrasound-on-chip technology under development agreement.

HeadquartersSan Mateo, US
Founded2020
Corporate funding$97M
Team51-200
Deployments1
Open roles5
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries B
FoundersJosh DeFonzo (CEO), Jason Wilson (CTO)
Regions servedNorth America
Countries deployedUS
Service footprintHQ San Mateo, CA; Focalist system FDA-cleared July 2025; limited US commercial launch 2025 in urology; full commercialization targeted for 2026
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

Focalist

  • Handheld robotic needle positioning with real-time ultrasound depth tracking and automatic repositioning

    vendor-stated capability for ultrasound-guided interventional procedures

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2025-09-11Mayo Clinic Arizonaacademic medical center, urology (PCNL)USNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordThreshold VenturesLux CapitalPFM Health SciencesFred Moll (angel)
HR

Hiring signal

Public job board · 2026-07-13

Open roles5

Hiring is an operating signal, not deployment evidence. Roles are refreshed from the company’s public careers system.

TL

Company timeline

Milestones and announcements

2025-09-11World's first Focalist procedures performed by Dr. Karen Stern at Mayo Clinic Arizona (PCNL for kidney stone treatment); limited US urology launch begun; expansion to additional specialties planned for 2026Mendaera
2025-07-08FDA 510(k) clearance granted for Focalist handheld robotic system; limited commercial launch initiated with select US institutionsBusiness Wire
2024-09-26Raised $73M Series B led by Threshold Ventures, with Lux Capital and PFM Health SciencesMendaera
2023-08-01Raised $24M Series A led by Lux CapitalThe Robot Report
SC

Source ledger

5 unique public sources